齊家控股(08395.HK):謝子謙出任公司祕書及授權代表
格隆匯9月30日丨齊家控股(08395.HK)宣佈,林耀祖已提請辭任公司的公司祕書,以及終止出任聯交所GEM證券上市規則第5.24條下的公司授權代表("授權代表"),由2021年10月1日起生效。
同日宣佈,集團與明大企業服務有限公司訂立一份公司祕書支援服務協議,據此,明大企業服務有限公司同意向公司提供公司祕書服務,由2021年10月1日起為期兩年。年度專業服務費為60,000港元,須按月支付,金額乃經參照當前市場收費後公平磋商釐定。
謝子謙為明大企業服務有限公司的經理,已獲指派為公司祕書及授權代表,接替林耀祖,由2021年10月1日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.